Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Weifang Shengtai Pharmaceutical is a leading Chinese manufacturer specializing in the production of pharmaceutical-grade glucose and starch-based products. Based in Weifang, Shandong Province, the company is one of the largest suppliers of dextrose monohydrate, anhydrous dextrose, and medicinal corn starch in China. Its products serve as critical raw materials and excipients for the pharmaceutical, food, and beverage industries, particularly in the formulation of intravenous solutions and oral medications. The company operates large-scale, GMP-compliant manufacturing facilities and maintains a significant presence in both domestic and international markets. Shengtai is a key player in the global supply chain for essential pharmaceutical energy sources and carbohydrate-based excipients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Weifang Shengtai Pharmaceutical.